homecourse contentcurrent volumeback volumessubscribecontact usfaq

« Previous IssueNext Issue »

All subscribers to ACOG UPDATE audio CDs will also have free access and ability to download the same program in MP3 format. They can also download a PDF file of the complete transcript with Pre- and Post-test Questions and a List of Supplementary Reading Materials.

Volume 42, Issue 6
Publication date: December 1, 2016
Expiration date: December 1, 2019

Antenatal Steroid Use: The Recommendations Keep Changing
Lisa M. Hollier, MD, MPH (Moderator)
Professor of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Baylor College of Medicine; Chief Medical Officer, Texas Children’s Health Plan, Houston, Texas

Cynthia Gyamfi-Bannerman, MD, MSc
Ellen Jacobson Levine and Eugene Jacobson Associate Professor of Women’s Health; Program Director, Maternal-Fetal Medicine Fellowship, Department of Obstetrics and Gynecology, Columbia University Medical Center, New York, New York

Alex C. Vidaeff, MD, MPH
Professor of Obstetrics and Gynecology; Program Director, Maternal-Fetal Medicine Fellowship, Department of Obstetrics and Gynecology, Baylor College of Medicine; Texas Children’s Hospital Pavilion for Women, Houston, Texas

Learning Objectives
After completing this activity, the physician should be better able to:
1. List the neonatal benefits of antenatal corticosteroids administered to infants <34 weeks.
2. Discuss the potential adverse effects of corticosteroid administration for preterm infants.
3. Identify appropriate patients for administration of antenatal corticosteroids in the late preterm period, based on the inclusion criteria for the Antenatal Late Preterm Steroids (ALPS) clinical trial.
4. Describe the biochemical mechanisms that contribute to the beneficial effect of antenatal corticosteroids on respiratory outcomes.
5. Recognize the candidates for administration of a repeat course of antenatal steroids.

Email Address


Forgot my password
Not registered?
Click here to Sign-up
Listen, Learn and Earn